Back
DarioHealth 10K Form
Sell
47
DRIO
DarioHealth
Last Price:
1.52
Seasonality Move:
-7.63%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-02 | 10Q | DRIO/DarioHealth Quarterly |
2023-08-10 | 10Q | DRIO/DarioHealth Quarterly |
2023-05-11 | 10Q | DRIO/DarioHealth Quarterly |
2022-11-14 | 10Q | DRIO/DarioHealth Quarterly |
2022-08-15 | 10Q | DRIO/DarioHealth Quarterly |
2022-05-12 | 10Q | DRIO/DarioHealth Quarterly |
Receive DRIO News And Ratings
See the #1 stock for the next 7 days that we like better than DRIO
DRIO Financial Statistics
Sales & Book Value
Annual Sales: | $20.35M |
---|---|
Cash Flow: | $-7.42M |
Price / Cash Flow: | 0 |
Annual Sales: | $2.14 |
Price / Book: | 0.77 |
Profitability
EPS (TTM): | -1.03000 |
---|---|
Net Income (TTM): | $-59.43M |
Gross Margin: | $5.98M |
Return on Equity: | -83.32% |
Return on Assets: | -54.3% |
DarioHealth Earnings Forecast
Key DarioHealth Financial Ratios
- The Gross Profit Margin over the past 11 years for DRIO is 29.40%.
- The Selling, General & Administrative Expenses for DRIO have been equal to 206.00% of Gross Profit Margin.
- The Research & Development expenses have been 99.49% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of DRIO is -292.00% of Total Revenues.
- Per Share Earnings over the last 12 years have been positive in 9 years.
DarioHealth Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Technology |
Sector: | Health Care |
Current Symbol: | DRIO |
CUSIP: | 23725P |
Website: | mydario.com |
Debt
Debt-to-Equity Ratio: | 0.49 |
---|---|
Current Ratio: | 3.79 |
Quick Ratio: | 3.24 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
DRIO Technical Analysis vs Fundamental Analysis
Sell
47
DarioHealth (DRIO)
is a Sell
Is DarioHealth a Buy or a Sell?
-
DarioHealth stock is rated a Sell
The current DarioHealth [DRIO] share price is $1.52. The Score for DRIO is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.